Filter
29
Filtered Results: 29
Text search:
vaxzevria
Featured
Recommendations
6
Language
Document type
Guidelines
17
Fact sheets
7
Studies & Reports
4
No document type
1
Countries / Regions
Ukraine
3
Brazil
3
Latin America and the Carribbean
2
Germany
2
Authors & Publishers
Publication Years
Category
COVID-19
6
Guidelines
3
Vaccine-preventable Diseases
2
Humanitarian Crisis
2
Policies
1
Studies & Reports
1
Pharmacy & Technologies
1
Toolboxes
Immunization Guidelines
9
Clinical Guidelines
7
Vaxzevria (Astra Zeneca)
6
Access & Strategy
4
SARS-CoV-2 Variants
2
Booster Doses
2
Situation Reports & Updates
2
Guidelines & Manuals
2
Europe
1
Vaccination
1
Pediatrics
1
Context & Facts, Travel Advice
1
For Parents & Children
1
For Pregnant Women
1
For People with Disabilities
1
Country specific documents
1
For Older People
1
Long-term Care Facilities
1
Fair Allocation & Ethical Aspects
1
COVAX Initiative
1
Long COVID/ Post-COVID Syndrome
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Johnson & Johnson
1
Research & Pipeline
1
Essential Medicines
1
Prices and Patents
1
Reports & Studies
1
General
1
Global Overview
1
Human Rights & the Right to Health
1
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
Empfehlungen des Robert Koch-Instituts für Alten- und Pflegeeinrichtungen und Einrichtungen für Menschen mit Beeinträchtigungen und Behinderungen und für den öffentlichen Gesundheitsdienst
Stand 7.4.2021
Weekly epidemiological update on COVID-19, 28 September 2022
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
Orientations provisoires 19 juillet 2021
interim guidance, 19 July 2021 (arabic version)
29 September 2021
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
Recommendations for the adaptation of Emergency Medical Teams (EMTs) at temporary sites for COVID-19 vaccination. Draft Version 2.3, November 2021
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
Emergency medical teams (EMTs) play an important role in strengthening health service networks in terms of their strategies and tactics for planning mass vaccination programs, especially in remote or under-resourced areas or those overwhelmed by COVID-19. EMTs experience deploying in remote areas an...
